Anne-Marie Duliege

This profile gathers the share dealings of Anne-Marie Duliege across 3 companies, led by Affymax Inc, Rigel Pharmaceuticals Inc and ChemoCentryx, Inc. We count 44 filings; the first trade dates from 15 May 2008 and the latest from 17 September 2018.

On the market, this insider has only sold: 26 sales, €2.3M in total. Other entries cover 3 share grants and 15 option exercises. In 2018 alone, the filings show no purchases and 5 sales.

Most recently, on 19 September 2018, the filings show an open-market sale worth €112k in Rigel Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.